Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
194
NCT00628264
Safety, Tolerability and Pharmacodynamics of AP214 Acetate in Patients Undergoing Cardiac Surgery
Phase: Phase 2
Role: Lead Sponsor
Start: Mar 31, 2008
Completion: Jun 30, 2009
NCT00903604
Pharmacokinetics of AP214 Acetate in Patients Undergoing Cardiac Surgery
Start: May 31, 2009
Completion: Jun 30, 2010
NCT01256372
An Trial of Two Dosing Regimens of AP214 for the Prevention of Kidney Injury in Patients Undergoing Cardiac Surgery
Start: Oct 31, 2010
Completion: Aug 31, 2011